North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Description
In-house Standards
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Vorapaxar (CAS <strong>618385-01-6</strong>) is a selective thrombin receptor antagonist used in cardiovascular therapy. Its synthesis involves complex organic coupling to ensure high purity for pharmaceutical grade standards. The molecular formula is C<sub>24</sub>H<sub>29</sub>N<sub>5</sub>O<sub>4</sub>.</p>
<h3>Application</h3>
<ul>
<li>Cardiovascular medicine: Adjunct therapy for reducing thrombotic events.</li>
<li>Clinical trials: Investigating efficacy in acute coronary syndromes.</li>
<li>R&D manufacturing: Supplying API intermediates for formulation development.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in patients with prior intracranial hemorrhage or stroke history. Store under controlled conditions at 2-8°C to maintain stability and prevent degradation during transport and storage.</p>